Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104
Field Trip Health (FTRP) was granted a US patent for its formulation of 4-HO-DiPT (aka Isoprocin Glutarate), an extremely intense psychedelic lasting 2-3 hours.
Field Trip will begin a Phase I safety trial within 3 months with hopes that it will lead to Phase II trials on treatment-resistant depression and postpartum depression.
